Tyler Zeronda - 31 Dec 2022 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
Chief Financial Officer
Signature
/s/ Mutya Harsch, attorney-in-fact for Tyler Zeronda
Issuer symbol
VYNE
Transactions as of
31 Dec 2022
Net transactions value
-$53.1
Form type
4
Filing time
04 Jan 2023, 16:05:41 UTC
Previous filing
04 Oct 2022
Next filing
04 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability $53.1 -354 -0.2% $0.1500 173,005 31 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.